These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16036868)

  • 1. Preclinical safety and pharmacokinetics of recombinant human factor XIII.
    Ponce RA; Visich JE; Heffernan JK; Lewis KB; Pederson S; Lebel E; Andrews-Jones L; Elliott G; Palmer TE; Rogge MC
    Toxicol Pathol; 2005; 33(4):495-506. PubMed ID: 16036868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of recombinant human factor XIII in a cynomolgus monkey model of extracorporeal blood circulation.
    Ponce R; Armstrong K; Andrews K; Hensler J; Waggie K; Heffernan J; Reynolds T; Rogge M
    Toxicol Pathol; 2005; 33(6):702-10. PubMed ID: 16243775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and pharmacokinetics of recombinant factor XIII in healthy volunteers: a randomized, placebo-controlled, double-blind, multi-dose study.
    Visich JE; Zuckerman LA; Butine MD; Gunewardena KA; Wild R; Morton KM; Reynolds TC
    Thromb Haemost; 2005 Oct; 94(4):802-7. PubMed ID: 16270634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety, pharmacokinetics, and immunogenicity of single-dose rFXIII administration to healthy volunteers.
    Reynolds TC; Butine MD; Visich JE; Gunewardena KA; MacMahon M; Pederson S; Bishop PD; Morton KM
    J Thromb Haemost; 2005 May; 3(5):922-8. PubMed ID: 15869585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. A preliminary report.
    Levy JH; Gill R; Nussmeier NA; Olsen PS; Andersen HF; Booth FV; Jespersen CM
    Thromb Haemost; 2009 Oct; 102(4):765-71. PubMed ID: 19806264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
    Williams M; Will A; Stenmo C; Rosholm A; Tehranchi R
    Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sushi domains in the B subunit of factor XIII responsible for oligomer assembly.
    Souri M; Kaetsu H; Ichinose A
    Biochemistry; 2008 Aug; 47(33):8656-64. PubMed ID: 18652485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of high molecular weight plasma protein complexes induced by clotting factor rFXIII-treatment in the cynomolgus monkey.
    Schaal-Jensen R; Kiehr B; Boesen HT; Krabbe JS; Sommer C; Jacobsen H; Oleksiewicz MB
    J Thromb Haemost; 2007 Oct; 5(10):2070-8. PubMed ID: 17650079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: a crossover randomised study.
    Brackmann HH; Egbring R; Ferster A; Fondu P; Girardel JM; Kreuz W; Masure R; Miloszewski K; Stibbe J; Zimmermann R
    Thromb Haemost; 1995 Aug; 74(2):622-5. PubMed ID: 8584996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency.
    Lovejoy AE; Reynolds TC; Visich JE; Butine MD; Young G; Belvedere MA; Blain RC; Pederson SM; Ishak LM; Nugent DJ
    Blood; 2006 Jul; 108(1):57-62. PubMed ID: 16556896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XIII deficiency enhances thrombin generation due to impaired fibrin polymerization - An effect corrected by Factor XIII replacement.
    Pitkänen HH; Jouppila A; Lemponen M; Ilmakunnas M; Ahonen J; Lassila R
    Thromb Res; 2017 Jan; 149():56-61. PubMed ID: 27902939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant factor XIII improves established experimental colitis in rats.
    D'Argenio G; Grossman A; Cosenza V; Valle ND; Mazzacca G; Bishop PD
    Dig Dis Sci; 2000 May; 45(5):987-97. PubMed ID: 10795765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical toxicity biomarkers for combination treatment with clotting factors rFXIII and rFVIIa.
    Oleksiewicz MB; Schaal-Jensen R; Kiehr B; Krabbe JS; Sommer C
    Biomarkers; 2007; 12(4):424-44. PubMed ID: 17564847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency.
    Kerlin B; Brand B; Inbal A; Halimeh S; Nugent D; Lundblad M; Tehranchi R
    J Thromb Haemost; 2014 Dec; 12(12):2038-43. PubMed ID: 25263390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
    Kerlin BA; Inbal A; Will A; Williams M; Garly ML; Jacobsen L; Kearney SL
    J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free factor XIII activation peptide (fAP-FXIII) is a regulator of factor XIII activity via factor XIII-B.
    Dodt J; Pasternack R; Seitz R; Volkers P
    Br J Haematol; 2016 Feb; 172(3):452-60. PubMed ID: 26516704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of recombinant factor XIII in cynomolgus monkeys.
    Dodds MG; Visich JE; Vicini P
    AAPS J; 2005 Oct; 7(3):E693-703. PubMed ID: 16353946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.